These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
3. Response to chemotherapy could predict the prognosis of esophageal squamous cell carcinoma treated with neoadjuvant docetaxel, cisplatin, and fluorouracil (DCF) followed by surgery: long-term results in a single institute. Sato Y; Mori K; Atsumi S; Sakamoto K; Oya S; Okamoto A; Urabe M; Miwa Y; Yajima S; Yagi K; Nomura S; Yamashita H; Seto Y Esophagus; 2024 Oct; 21(4):514-522. PubMed ID: 38987434 [TBL] [Abstract][Full Text] [Related]
4. Survival comparison between open and thoracoscopic esophagectomy for node-negative esophageal squamous cell cancer: an ambispective cohort study. Jia X; Ren T; Chen P; Xin X; Zhang Y; Yang Y Surg Endosc; 2024 Dec; 38(12):7341-7351. PubMed ID: 39433581 [TBL] [Abstract][Full Text] [Related]
5. The impact of time to postoperative recurrence on the prognosis of patients with esophageal cancer post recurrence: exploratory analysis of OGSG 1003. Hori S; Yamasaki M; Yamamoto N; Harino T; Momose K; Yamashita K; Tanaka K; Sugimura K; Makino T; Takeno A; Shiraishi O; Motoori M; Miyata H; Kimura Y; Hirao M; Yasuda T; Yano M; Doki Y Esophagus; 2024 Oct; 21(4):472-483. PubMed ID: 39174706 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Effect of the PNI and LSR in Patients with Esophageal Squamous Cell Carcinoma Patients Receiving Radiotherapy. Gao J; Li M; Wang Y; Wang Z; Chen X; Li H J Gastrointest Cancer; 2024 Nov; 56(1):26. PubMed ID: 39601941 [TBL] [Abstract][Full Text] [Related]
7. Comparison of proton-based definitive chemoradiotherapy and surgery-based therapy for esophageal squamous cell carcinoma: a multi-center retrospective Japanese cohort study. Ogawa K; Ishikawa H; Toyozumi T; Noma K; Kono K; Hojo H; Tamamura H; Azami Y; Ishida T; Nabeya Y; Iwata H; Araya M; Tokumaru S; Maruo K; Oda T; Matsubara H Esophagus; 2024 Oct; 21(4):484-494. PubMed ID: 38844703 [TBL] [Abstract][Full Text] [Related]
8. [Neoadjuvant chemoradiotherapy versus neoadjuvant chemo-immunotherapy for locally advanced esophageal squamous cell carcinoma]. Wang XY; Shen HX; Li RH; Wang JF; Fang M; Tao KY; Jiang YH; Ji YL Zhonghua Zhong Liu Za Zhi; 2024 Nov; 46(11):1058-1066. PubMed ID: 39622738 [No Abstract] [Full Text] [Related]
9. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661 [TBL] [Abstract][Full Text] [Related]
10. Serum and urine nucleic acid screening tests for BK polyomavirus-associated nephropathy in kidney and kidney-pancreas transplant recipients. Maung Myint T; Chong CH; von Huben A; Attia J; Webster AC; Blosser CD; Craig JC; Teixeira-Pinto A; Wong G Cochrane Database Syst Rev; 2024 Nov; 11(11):CD014839. PubMed ID: 39606952 [TBL] [Abstract][Full Text] [Related]
11. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
12. Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial. Kim P; Sanchez AM; Penke TJR; Tuson HH; Kime JC; McKee RW; Slone WL; Conley NR; McMillan LJ; Prybol CJ; Garofolo PM Lancet Infect Dis; 2024 Dec; 24(12):1319-1332. PubMed ID: 39134085 [TBL] [Abstract][Full Text] [Related]
14. Trends in Surgical and Nonsurgical Aesthetic Procedures: A 14-Year Analysis of the International Society of Aesthetic Plastic Surgery-ISAPS. Triana L; Palacios Huatuco RM; Campilgio G; Liscano E Aesthetic Plast Surg; 2024 Oct; 48(20):4217-4227. PubMed ID: 39103642 [TBL] [Abstract][Full Text] [Related]
15. Predictive and Prognostic Value of Inflammatory and Nutritional Indexes in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy. Arici MO; Kivrak Salim D; Kocer M; Alparslan AS; Karakas BR; Ozturk B Medicina (Kaunas); 2024 Nov; 60(11):. PubMed ID: 39597034 [No Abstract] [Full Text] [Related]
16. Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis. Shabaninejad H; Kenny RP; Robinson T; Stoniute A; O'Keefe H; Still M; Thornton C; Pearson F; Beyer F; Meader N Health Technol Assess; 2024 Oct; 28(75):1-75. PubMed ID: 39487741 [TBL] [Abstract][Full Text] [Related]
17. Preoperative D‑dimer level and prognosis in patients diagnosed with gastric cancer and undergoing gastric cancer radical surgery: A retrospective cohort study. Zhao Y; Han J; Yang R; Wang S; Zhang K; Lu H Oncol Lett; 2025 Jan; 29(1):64. PubMed ID: 39619170 [TBL] [Abstract][Full Text] [Related]
18. A novel disulfidptosis-related LncRNA prognostic risk model: predicts the prognosis, tumor microenvironment and drug sensitivity in esophageal squamous cell carcinoma. Ye C; Xu C; Tang Y; Qi Y; Peng X; Wei G; Jiang L BMC Gastroenterol; 2024 Nov; 24(1):437. PubMed ID: 39604874 [TBL] [Abstract][Full Text] [Related]
19. A novel staging system based on deep learning for overall survival in patients with esophageal squamous cell carcinoma. Zhang H; Jiang X; Yu Q; Yu H; Xu C J Cancer Res Clin Oncol; 2023 Sep; 149(11):8935-8944. PubMed ID: 37154930 [TBL] [Abstract][Full Text] [Related]